NL-OMON21808已完成不适用
TApering strategies in TNFi&MTX induced remission in Rheumatoid Arthritis. Should we taper MTX or TNFi first?
Erasmus MC, Rotterdam0 个研究点目标入组 355 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 355
研究概览
简要总结
DOI: 10.1136/annrheumdis-2018-214970
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. RA patients;
- •2. Aged >17 years;
排除标准
- •1. Not being able to understand, speak and write in Dutch;
- •2. Being diagnosed with a psychiatric or personality disorder.
研究者
相似试验
已完成
不适用
To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.Rheumatoid ArthritisNCT05576051Pfizer9,159
已完成
不适用
OPtimising Treatment with Tumour necrosis factor (TNF) Inhibitors in Rheumatoid Arthritis: is dose tapering practical in good responders?Musculoskeletal DiseasesRheumatoid arthritisISRCTN28955701King's College London (KCL) (UK)99
进行中（未招募）
1 期
Rotation or Change of Biotherapy After TNF blocker treatment failureaxial SpondyloarthritisMedDRA version: 20.0 Level: PT Classification code 10071400 Term: Axial spondyloarthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2017-004700-22-FRCHU SAINT-Etienne
已完成
不适用
Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPNHenoch-Schoenlein PurpuraNephritisNCT00301613Nanjing University School of Medicine60
已完成
2 期
Teverelix Evaluated in Advanced Prostate CancerProstatic AdenomaNCT04693507Antev Ltd.50